Skip to content
10-Q

Quarterly Report

MOSAIC IMMUNOENGINEERING, INC. CPMV

0001683168-25-003880

← back to feed
Filed
May 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 20, 2025 7.24M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $85.93K
Cash And Equivalents Q1 2025 · Dec 31, 2024 $115.02K
Current Liabilities Q1 2025 · Mar 31, 2025 $5.66M
Current Liabilities Q1 2025 · Dec 31, 2024 $5.54M
Total Liabilities Q1 2025 · Mar 31, 2025 $7.07M
Total Liabilities Q1 2025 · Dec 31, 2024 $6.93M
Current Assets Q1 2025 · Mar 31, 2025 $97.78K
Current Assets Q1 2025 · Dec 31, 2024 $141.61K
Total Assets Q1 2025 · Mar 31, 2025 $97.78K
Total Assets Q1 2025 · Dec 31, 2024 $141.61K
Shares Diluted Q1 2025 · Mar 31, 2024 7.24M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$91.14K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$6.15M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$5.87M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.04
Eps Basic Q1 2025 · Mar 31, 2024 −$0.04
Rd Expense Q1 2025 · Mar 31, 2024 $67.31K
Net Income Q1 2025 · Mar 31, 2024 −$288.49K
Operating Income Q1 2025 · Mar 31, 2024 −$268.77K